K292-2030 Screening compound: N-(2-ethoxyphenyl)-2-({4-oxo-3-[(pyridin-2-yl)methyl]-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)butanamide

K292-2030 Screening compound: N-(2-ethoxyphenyl)-2-({4-oxo-3-[(pyridin-2-yl)methyl]-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)butanamide
K292-2030 Screening compound: N-(2-ethoxyphenyl)-2-({4-oxo-3-[(pyridin-2-yl)methyl]-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K292-2030
N-(2-ethoxyphenyl)-2-({4-oxo-3-[(pyridin-2-yl)methyl]-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K292-2030

Molecular Formula

C24H24N4O3S2 (C24 H24 N4 O3 S2)

Compound Name

N-(2-ethoxyphenyl)-2-({4-oxo-3-[(pyridin-2-yl)methyl]-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)butanamide

IUPAC name

N-(2-ethoxyphenyl)-2-({4-oxo-3-[(pyridin-2-yl)methyl]-3H4H-thieno[32-d]pyrimidin-2-yl}sulfanyl)butanamide

SMILES

CCC(C(Nc(cccc1)c1OCC)=O)SC(N(Cc1ncccc1)C1=O)=Nc2c1scc2

InChI

InChI=1S/C24H24N4O3S2/c1-3-20(22(29)26-17-10-5-6-11-19(17)31-4-2)33-24-27-18-12-14-32-21(18)23(30)28(24)15-16-9-7-8-13-25-16/h5-14,20H,3-4,15H2,1-2H3,(H,26,29)/t20-/m0/s1

InChI Key

OIFMOFQTCODGTN-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD15092183

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.61

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.585

Distribution Coefficient, logD

4.584

Water Solubility, LogSw

-4.19

Polar Surface Area

66.208

Acid Dissociation Constant (pKa)

11.15

Base Dissociation Constant (pKb)

3.10

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

25.00

K292-2030 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with K292-2030 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K292-2030?
Check Price and Availability of K292-2030, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K292-2030 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K292-2030
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K292-2030
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K292-2030 available by request